Class III
Terminated
Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only.
Why: Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
- Company
- Gilead Sciences, Inc.
Foster City, CA, United States - Reported
- Mar 5, 2014
- Recall started
- Feb 19, 2014
- Ended
- May 11, 2015
- Where sold
- Nationwide including Puerto Rico.
- Amount
- 39,223 bottles
- Full product description
- Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only. Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404. Made in Ireland. NDC 15584-0101-1. Manufactured for: Bristol-Myers-Squibb & Gilead Sciences, LLC, Foster City, CA 94404 Made in Ireland
- Lots / codes affected
- Lot #'s: 002390, 002400, Exp 02/17.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.